MED
Medifast, Inc.
$12.59
-0.04
(-0.32%)
Mkt Cap
139.99M
Volume
108,603
52W Range
9.22-15.46
Sector
Consumer Cyclical
Beta
0.57
EPS (TTM)
-1.82
P/E Ratio
-6.28
Revenue (TTM)
346.10M
Rev Growth (5Y)
-16.2%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
$111.60
Undervalued · Strong
88.7% below fair value
AlphaQuality · Grade
C
Stable Earnings Power
52.9 / 100 composite
Company Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 385.79M | 602.46M | 1.07B | 1.60B | 1.53B | 934.84M | 713.67M | 501.00M | 301.56M | 274.53M | 272.77M | 285.29M |
| Net Income | (18.67M) | 2.09M | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M | 55.79M | 27.72M | 17.84M | 20.06M | 13.18M |
| EPS | -1.70 | 0.19 | 9.10 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 | 2.32 | 1.51 | 1.68 | 1.04 |
| Free Cash Flow | 1.25M | 17.02M | 141.17M | 177.89M | 60.34M | 139.31M | 74.20M | 55.88M | 39.99M | 22.47M | N/A | N/A |
| FCF / Share | 0.11 | 1.56 | 12.97 | 15.89 | 5.15 | 11.83 | 6.30 | 4.68 | 3.35 | 1.90 | N/A | N/A |
| Operating CF | 6.86M | 24.48M | 147.66M | 194.57M | 94.55M | 145.20M | 84.26M | 60.82M | 43.24M | 25.35M | N/A | N/A |
| Total Assets | 257.01M | 284.21M | 309.91M | 316.21M | 398.33M | 276.08M | 194.65M | 169.43M | 145.93M | 121.22M | N/A | N/A |
| Total Debt | 16.79M | 16.12M | 22.01M | 26.05M | 32.54M | 11.16M | 13.60M | 0 | 0 | 779,000 | N/A | N/A |
| Cash & Equiv | 89.30M | 90.93M | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.08M | 52.44M | N/A | N/A |
| Book Value | 198.92M | 210.11M | 201.48M | 155.04M | 202.47M | 157.25M | 104.83M | 109.11M | 108.58M | 96.02M | N/A | N/A |
| Return on Equity | -0.09 | 0.01 | 0.49 | 0.93 | 0.81 | 0.65 | 0.74 | 0.51 | 0.26 | 0.19 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76.04M | 75.10M | 89.41M | 105.56M | 115.73M | 119.00M | 140.16M | 168.56M | 174.74M | 191.01M | 235.87M | 296.19M |
| Net Income | (2.12M) | (18.12M) | (2.26M) | 2.48M | (772,000) | 801,000 | 1.13M | (8.15M) | 8.32M | 6.04M | 23.13M | 30.28M |
| EPS | -0.19 | -1.65 | -0.21 | 0.23 | -0.07 | 0.07 | 0.10 | -0.75 | 0.76 | 0.50 | 2.12 | 2.78 |
| Free Cash Flow | (836,000) | (6.63M) | 10.75M | (4.76M) | 1.88M | (7.23M) | 7.68M | 11.13M | 5.44M | 9.58M | 28.25M | 41.40M |
| FCF / Share | -0.08 | -0.60 | 0.98 | -0.43 | 0.17 | -0.66 | 0.70 | 1.02 | 0.50 | 0.88 | 2.59 | 3.80 |
| Operating CF | 260,000 | (5.28M) | 12.11M | (3.38M) | 3.41M | (4.95M) | 9.07M | 13.07M | 7.28M | 10.52M | 29.93M | 43.15M |
| Total Assets | 252.05M | 257.01M | 268.21M | 269.33M | 280.01M | 284.21M | 291.24M | 293.53M | 302.76M | 309.91M | 320.02M | 318.73M |
| Total Debt | 16.10M | 16.79M | 12.26M | 13.07M | 14.61M | 16.12M | 17.62M | 19.10M | 20.57M | 22.01M | 22.34M | 23.67M |
| Cash & Equiv | 71.53M | 89.30M | 99.53M | 101.69M | 91.72M | 90.93M | 115.31M | 108.02M | 97.47M | 94.44M | 112.75M | 147.41M |
| Book Value | 197.68M | 198.92M | 214.71M | 216.00M | 210.96M | 210.11M | 207.34M | 205.28M | 210.96M | 201.48M | 193.03M | 185.56M |
| Return on Equity | -0.01 | -0.09 | -0.01 | 0.01 | -0.00 | 0.00 | 0.01 | -0.04 | 0.04 | 0.03 | 0.12 | 0.16 |
MED News
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Why Medifast's $15 Cash Per Share Makes It A Strong Buy
Medifast: Worth Putting On A Watchlist
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast Announces First Quarter 2026 Financial Results